Results 271 to 280 of about 288,723 (312)
Some of the next articles are maybe not open access.
Diagnosis of advanced gastric cancer
World Journal of Surgery, 1979AbstractA series of 536 patients who underwent gastric resections for advanced gastric cancer has been reviewed with regard to the diagnostic procedures for detecting gastric cancer. There were no characteristic symptoms of gastric cancer, but weight loss was a frequent complaint. Variation in the type and frequency of symptoms did not appear to depend
F, Nagao, N, Takahashi
openaire +2 more sources
Capecitabine in advanced gastric cancer
Expert Opinion on Pharmacotherapy, 2007Since the routine introduction of chemotherapy for advanced gastric cancer in the early 1990 s, median survival for gastric cancer has improved from 3 months, with best supportive care alone, to > 11 months in recently reported Phase III trials of triplet chemotherapy.
Alicia, Okines +2 more
openaire +2 more sources
MMAF for advanced gastric cancer
European Journal of Cancer and Clinical Oncology, 199165 patients with metastatic gastric carcinoma were treated with a combination of methotrexate 1.5 g/m2 with 5-fluorouracil 1.5 g/m2 on day 1 and doxorubicin 30 mg/m2 with mitomycin 4 mg/m2 on day 14. Cycles of chemotherapy were repeated every 4 weeks. The overall response rate was 29% with 6% complete responses and 23% partial responses.
H, Anderson +7 more
openaire +2 more sources
Targeted Therapies in Advanced Gastric Cancer
Current Treatment Options in Oncology, 2020Despite a decreasing incidence in the USA, gastric cancer is highly prevalent worldwide. Furthermore, gastric cancer remains highly lethal with median survival of less than 1 year for metastatic disease. The backbone of therapy against metastatic gastric cancer remains cytotoxic chemotherapy, but recent advances in the molecular understanding of ...
Timil H. Patel, Michael Cecchini
openaire +2 more sources
Laparoscopic Gastrectomy for Advanced Gastric Cancer
The American Surgeon™, 2023Background Application of laparoscopic gastrectomy (LG) to advanced gastric cancer is still controversial due to lack of sufficient surgical and oncological outcomes. The purpose of this study was to elucidate the feasibility of LG for advanced gastric cancer by multicenter prospective cohort study. Methods A total of 98 patients with clinical stage II
Kazuyoshi, Yamamoto +11 more
openaire +2 more sources
Recent advances in gastric cancer.
Gastroenterology and hepatology from bed to bench, 2014Shi M et al. XB130 promotes proliferation and invasion of gastric cancer cells. J Transl Med 2014;12:1 In addition to enhancing the survival, proliferation and metastasis of thyroid cancer cells the adaptor protein XB130 may also be implicated in gastric cancer (GC). This study investigated the effects of XB130 on GC in vitro and in vivo.
openaire +2 more sources
2014
Worldwide, gastric cancer-related mortality has declined dramatically since the 1930s. However, gastric cancer remains a lethal disease, especially when it is diagnosed at an advanced stage. In advanced gastric cancer, the lesion extends beyond the proper muscle layer. Advanced gastric cancers are usually classified into four types (types 1–4) by their
openaire +1 more source
Worldwide, gastric cancer-related mortality has declined dramatically since the 1930s. However, gastric cancer remains a lethal disease, especially when it is diagnosed at an advanced stage. In advanced gastric cancer, the lesion extends beyond the proper muscle layer. Advanced gastric cancers are usually classified into four types (types 1–4) by their
openaire +1 more source
Chemotherapy for advanced gastric cancer
2002Gastric cancer currently ranks second in global cancer mortality. Most patients are either diagnosed at an advanced stage, or develop a relapse after surgery with curative intent. Apart from supportive care and palliative radiation to localized (e.g.
A D, Wagner +6 more
openaire +3 more sources
Noncurative resection for advanced gastric cancer
Journal of Surgical Oncology, 1992AbstractBetween 1965 and 1985, 489 patients with advanced gastric cancer who were treated with gastric resection and in whom tumor cells remained after the operation were defined as cases of a “noncurative resection.” The clinicopathological features and prognosis of these patients were examined and two groups were prepared: locally advanced cancer and
Y, Maehara +6 more
openaire +2 more sources
Optimal surgery for advanced gastric cancer
Expert Review of Anticancer Therapy, 2009Locoregional control remains a major problem after surgery, although a curative resection is still the only treatment to offer a cure for patients with gastric cancer. Despite the results of major randomized trials, the extent of nodal dissection continues to be debated.
Ilfet, Songun, Cornelis Jh, van de Velde
openaire +2 more sources